Clinical Trial Update: E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 trial of E7080 (lenvatinib) in combination with carboplatin and paclitaxel in non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• E7080 (lenvatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Non-small-cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-03-06